Research location
Waterloo
Ontario, Canada
Advertisement
Research activity in Waterloo
Ontario, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 92 trials and 96 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Waterloo
92 linked trials · page 2 of 2Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal InsulinNCT02963922 · 2017-02-06 · 1 site observation
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With InsulinNCT03021187 · 2017-02-02 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled AsthmaNCT02924688 · 2016-10-13 · 1 site observation
COMPLETED
Orthotics and Parkinson's Disease: The Acute and Long-term Effects of Increased Somatosensory FeedbackNCT02809391 · 2016-07-01 · 1 site observation
UNKNOWN
PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNadaNCT02957409 · 2016-05-20 · 1 site observation
COMPLETED
Evaluation of a New Method for Instilling Eye DropsNCT02697318 · 2016-05-01 · 1 site observation
COMPLETED
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesNCT02730377 · 2016-03-28 · 1 site observation
COMPLETED
Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life SettingNCT02690974 · 2016-03-08 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
Two Resistance Training Protocols to Reduce the Risk of Falls in Parkinson's DiseaseNCT02476266 · 2015-08-01 · 1 site observation
COMPLETED
The Cerebellum as a Potential Treatment Site for PD Motor SymptomsNCT02387346 · 2015-04-01 · 1 site observation
UNKNOWN
Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and OlderNCT02392754 · 2015-04-01 · 1 site observation
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation
COMPLETED
Whole-body Vibration as a Treatment for Parkinson's DiseaseNCT02306863 · 2015-01-01 · 1 site observation
UNKNOWN
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration AlgorithmsNCT02298192 · 2014-11-21 · 1 site observation
COMPLETED
Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's SyndromeNCT02203188 · 2014-08-01 · 1 site observation
COMPLETED
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart FailureNCT01970501 · 2014-04-01 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 DiabetesNCT01819129 · 2013-09-09 · 1 site observation
COMPLETED
Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 DiabetesNCT01720446 · 2013-02-21 · 1 site observation
COMPLETED
Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesNCT01734785 · 2013-02-08 · 1 site observation
COMPLETED
MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptinNCT01792518 · 2013-02-01 · 1 site observation
COMPLETED
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma PatientsNCT01682460 · 2012-08-01 · 1 site observation
COMPLETED
Evaluation of Nutrition and Metabolism in Breast Cancer PatientsNCT01542216 · 2012-02-01 · 1 site observation
WITHDRAWN
Metabolic Effects of Treatment in Intermediate and High-Risk Prostate CancerNCT01599182 · 2012-02-01 · 1 site observation
COMPLETED
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisNCT01490632 · 2011-12-01 · 1 site observation
COMPLETED
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisNCT01276639 · 2011-03-01 · 1 site observation
COMPLETED
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisNCT01309737 · 2011-03-01 · 1 site observation
COMPLETED
Clinical Trial of Menu LabelingNCT01948752 · 2010-11-01 · 1 site observation
COMPLETED
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisNCT01163253 · 2010-09-01 · 1 site observation
TERMINATED
ARI103094-Follow-Up Study for REDUCE Study SubjectsNCT00883909 · 2009-04-09 · 1 site observation
COMPLETED
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesNCT00736879 · 2008-09-22 · 1 site observation
COMPLETED
Sensory Attention Focused Exercise in Parkinson's DiseaseNCT01246700 · 2008-06-01 · 1 site observation
UNKNOWN
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye DiseaseNCT00809003 · 2007-09-01 · 1 site observation
COMPLETED
Study In People With Type 2 DiabetesNCT00196989 · 2005-09-01 · 1 site observation
COMPLETED
A New Oral Treatment For Type II Diabetes MellitusNCT00111800 · 2005-04-28 · 1 site observation
COMPLETED
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaNCT00330785 · 2004-10-01 · 1 site observation
COMPLETED
A Long-term Safety Study of Infliximab (Remicade)NCT00261976 · 2002-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.